Literature DB >> 21630123

The safety of multiple re-excisions after lumpectomy for breast cancer.

Suzanne Coopey1, Barbara L Smith, Stephanie Hanson, Julliette Buckley, Kevin S Hughes, Michele Gadd, Michelle C Specht.   

Abstract

BACKGROUND: Breast cancer patients may undergo multiple re-excisions after lumpectomy in an attempt to obtain clear margins and avoid mastectomy. We sought to determine the overall local recurrence rate and surgical outcome of patients undergoing two or more re-excisions and to identify predictors of success in attaining clear margins.
METHODS: Retrospective review of breast cancer patients who underwent lumpectomy for invasive cancer or ductal carcinoma in situ (DCIS) from 1997 to 2007. Patients who underwent two or more re-excisions were identified and analyzed.
RESULTS: We identified 3,737 patients who underwent lumpectomy over this 10-year period. 875 (23.4%) had close or positive margins requiring a second procedure; 797 (91.1%) had a re-excision; and 78 (8.9%) went directly to mastectomy. Seventy patients underwent multiple re-excisions; 66 patients had 2 re-excisions, 3 patients had 3 re-excisions, and 1 patient had 4 re-excisions. 70% (49/70) of multiple re-excision patients achieved clear margins (26 DCIS, 35 T1, 8 T2, and 1 T3 tumors). All 49 patients who successfully treated with multiple re-excisions received radiation. At a median follow-up of 64 months, 1 of 49 (2.0%) patients had an in-breast recurrence, and 1 of 49 (2.0%) patients had a distant recurrence. Statistically significant risk factors for persistently involved margins after two re-excisions included multifocality and positive lymph node status.
CONCLUSION: Multiple re-excisions to obtain clear margins are a safe alternative to mastectomy for women with invasive cancer or DCIS. There is an acceptably low risk of local and systemic failure when negative margins are ultimately achieved.

Entities:  

Mesh:

Year:  2011        PMID: 21630123     DOI: 10.1245/s10434-011-1802-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

1.  Re-excision Rates and Local Recurrence in Breast Cancer Patients Undergoing Breast Conserving Therapy.

Authors:  M Dieterich; H Dieterich; H Moch; C Rosso
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-11       Impact factor: 2.915

2.  Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system.

Authors:  Barbara L Smith; Michele A Gadd; Conor R Lanahan; Upahvan Rai; Rong Tang; Travis Rice-Stitt; Andrea L Merrill; David B Strasfeld; Jorge M Ferrer; Elena F Brachtel; Michelle C Specht
Journal:  Breast Cancer Res Treat       Date:  2018-06-09       Impact factor: 4.872

3.  The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.

Authors:  Kari M Rosenkranz; Karla Ballman; Linda McCall; Charlotte Kubicky; Laurie Cuttino; Huong Le-Petross; Kelly K Hunt; Armando Giuliano; Kimberly J Van Zee; Bruce Haffty; Judy C Boughey
Journal:  Ann Surg Oncol       Date:  2018-07-09       Impact factor: 5.344

Review 4.  Current status of ultrasound-guided surgery in the treatment of breast cancer.

Authors:  José H Volders; Max H Haloua; Nicole Ma Krekel; Sybren Meijer; Petrousjka M van den Tol
Journal:  World J Clin Oncol       Date:  2016-02-10

5.  Radiological Underestimation of Tumor Size Influences the Success Rate of Re-Excision after Breast-conserving Surgery.

Authors:  Duncan Simpson; Jennifer Allan; Brendan McFall
Journal:  Eur J Breast Health       Date:  2021-10-04

6.  Reoperations after primary breast conserving surgery in women with invasive breast cancer in Catalonia, Spain: a retrospective study.

Authors:  J M Escribà; L Esteban; J Gálvez; M J Pla; A Melià; M Gil-Gil; R Clèries; L Pareja; X Sanz; M Bustins; J M Borrás; J Ribes
Journal:  Clin Transl Oncol       Date:  2016-09-13       Impact factor: 3.405

7.  Development and Validation of the BREAST-Q Breast-Conserving Therapy Module.

Authors:  Anne F Klassen; Laura Dominici; Sarah Fuzesi; Stefan J Cano; Dunya Atisha; Tracie Locklear; Madelijn L Gregorowitsch; Elena Tsangaris; Monica Morrow; Tari King; Andrea L Pusic
Journal:  Ann Surg Oncol       Date:  2020-01-21       Impact factor: 5.344

8.  Similar rates of residual disease in patients with DCIS within 2 mm of lumpectomy margin regardless of the presence of invasive carcinoma.

Authors:  Bridget N Kelly; Olga Kantor; Rong Tang; Suzanne B Coopey; Barbara L Smith; Conor R Lanahan; Jenna E Korotkin; Michelle C Specht
Journal:  Breast Cancer Res Treat       Date:  2020-11-28       Impact factor: 4.872

9.  Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic.

Authors:  Laura M Spring; Michelle C Specht; Rachel B Jimenez; Steven J Isakoff; Gary X Wang; Amy Ly; Jennifer A Shin; Aditya Bardia; Beverly Moy
Journal:  N Engl J Med       Date:  2020-07-01       Impact factor: 91.245

10.  Factors Associated with Re-excision after Breast-Conserving Surgery for Early-Stage Breast Cancer.

Authors:  Woohyun Jung; Eunyoung Kang; Sun Mi Kim; Dongwon Kim; Yoonsun Hwang; Young Sun; Cha Kyong Yom; Sung-Won Kim
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.